UnitedHealth’sUNH

myriad of problems have landed the healthcare giant in the emergency room. Following a devastating cyberattack that impacted around 190M Americans’ sensitive medical data and the tragic loss of a top executive, the company now faces a Department of Justice (DoJ) investigation over its practices — adding another layer of trouble for the healthcare provider already navigating troubled waters on multiple fronts.

Record highs vs. legal lows: In 2024, UnitedHealth brought in record revenues of $400.3B but saw its net income dip to $14.4B, its weakest showing since 2019. It wasn’t just because of higher medical costs and utilization — it was also a product of expenses from the Change Healthcare cyberattack. And now, a new DOJ investigation threatens to take a bite out of UHC’s business in 2025 — claiming that UnitedHealth may have falsified records to secure higher Medicare payments. This scrutiny comes at a time when the DOJ is also engaged in an antitrust probe and is attempting to block UnitedHealth’s $3.3B acquisition of Amedisys.

• The DOJ’s attorneys recently interviewed medical providers about specific diagnoses UnitedHealth promoted, incentive arrangements, and pressure to add diagnoses — with at least two providers sharing documentation with investigators.
• The reports revealed that UnitedHealth received billions in questionable Medicare payments, with each in-home nurse visit generating an average of $2.7K in additional federal payments between 2019-2021.

Strategic Medicine

The new case causedUNH

to fall more than 9% on Friday, adding to an already sour air around the healthcare corporation, which has faced PR headwinds galore in recent years despite the fact it spends a larger share of its revenue on medical costs. In 2022, the business’ medical care ratio rose, with spending increasing from 82% that year to 85.5% in 2024. To combat these challenges, the firm is aiming to reduce operating expenses while cutting down on staff to save costs.

• The company has already initiated a voluntary buyout program targeting about 30K workers in its benefits operations unit, with a Mar. 3 deadline and potential layoffs if resignation goals are not achieved.
• However, UnitedHealth’s CEO Andrew Witty emphasized they’re “just scratching the surface” of technological opportunities and that the organizationy is still maintaining growth with 3.2K open positions.

Prescription of faith: Despite the turbulence, analysts are overwhelmingly backing the stock — with 22 of 24 issuing “Strong Buy” ratings and keeping ambitious price targets. Firms like Bernstein and Cantor Fitzgerald remain especially bullish, setting targets of $697 and $700, implying a potential upside of ~53% from current levels. Mizuho analyst Ann Hynes suggests buying the dip, noting that while DOJ investigations are never good for a company, they “do not expect an incremental negative [earnings per share] impact as a result of this investigation.” Regardless,UNH

is still down 12% in the past year, significantly underperforming the broader S&P 500’s 22% gain.